Innovative services & quality deliverables to accelerate your research program
Oncodesign Services is a contract research organization (CRO) specialized in drug discovery whose mission is to contribute to the discovery of innovative therapies against cancers and serious diseases with high medical needs.
Find out more about what we can offer you depending on the stage of development of your drug discovery project!
Drug candidate
Our solution:
Solo
- POC Oncology
- POC Inflammation
- COVID-19
- Pharmaco-Imaging & MRT
- DMPK – Bioanalysis
- Microbiome
Our Therapeutic Areas
Oncology
Since the inception of the company, we have been pioneering in translational pharmacology to study and treat cancer...
Inflammation
We have a big collection of preclinical inflammatory and autoimmune models, covering diseases of the skin, gut, lungs, kidneys, liver and more...
Infectious diseases
We have BSL2 and BSL3 facilities and local partnerships allowing infectious diseases models to be run...
31/03/2025
Oncodesign Services has appointed Dr. Aidan Synnott as chief executive officer, to help strengthen its position as a trusted partner in drug discovery.
27/03/2025
Oncodesign Services wins "Oncology CRO of the Year 2025 – France" for the second year, highlighting excellence in drug discovery and preclinical oncology research.
03/03/2025
Characterizing the inhibition of PRMT5:MTA by MRTX1719, a clinical stage MTAP-deleted cancer therapeutic.